Besides gene expression-based analyses, we also performed immunohistochemistry (IHC) with our 9 SCLC tumor samples to quantify tumor-infiltrating CD8+ and CD4+ T cells (Supplementary Data 2). This evidence concerns the gene CD4 and small cell lung carcinoma.